Regulation of Inflammatory Genes in Hidradenitis Suppurativa

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT05507125
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Mental health — BEHAVIORAL
    Early life exposure to abuse and development of hidradenitis suppurativa

Study Details

The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are diff erenti ally expressed in hidradeniti s pati ents versus controlalso doing a sub-study to determine the eff ect of childhood trauma on HS. The parti cipati on in the sub-study is opti onal

Key Dates

Start date
Oct 11, 2022
Status verified
Aug 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2028

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Control
    Participants without inflammatory skin disease
  • Arm: Patients with HS
    Patients with HS

Primary Outcome Measure

Inflammatory biomarkers [ Time Frame: 24 hours after application ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Whitaker ClinicBirminghamAlabama35294
Nabiha Yusuf
[email protected]
2059347432

Find similar trials in Birmingham, AL

By condition
Hidradenitis suppurativa
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Whitaker Clinic· Birmingham, AL

Related Studies